| 2021 |
Barratt KR, Sawyer RK, Atkins GJ, St-Arnaud R, Anderson PH. Vitamin d supplementation improves bone mineralisation independent of dietary phosphate in male X-linked hypophosphatemic (Hyp) mice. Bone. February 2021;143:115767. |
0 |
0 |
| 2021 |
Tippen SP, Noonan ML, Ni P, Metzger CE, Swallow EA, Sacks SA, Chen NX, Thompson WR, Prideaux M, Atkins GJ, Moe SM, Allen MR, White KE. Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. May 2021;146:115885. |
3 |
2 |
| 2021 |
Stapledon CJM, Stamenkov R, Cappai R, Clark JM, Bourke A, Solomon LB, Atkins GJ. Relationships between the bone expression of Alzheimer’s disease-related genes, bone remodelling genes and cortical bone structure in neck of femur fracture. Calcif Tiss Int. May 2021;108(5):610-621. |
0 |
0 |
| 2021 |
Noonan ML, Ni P, Agoro R, Sacks SA, Swallow EA, Wheeler JA, Clinkenbeard EL, Capitano ML, Prideaux M, Atkins GJ, Thompson WR, Allen MR, Broxmeyer HE, White KE. The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of circulating FGF23 in a CKD mouse model. J Bone Miner Res. June 2021;36(6):1117-1130. |
0 |
0 |
| 2022 |
Bliuc D, Tran T, Adachi JD, Atkins GJ, Berger C, van den Bergh J, Cappai R, Eisman JA, van Geel T, Geusens P, Goltzman D, Hanley DA, Josse R, Kaiser S, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Solomon LB, Stapledon C, Center JR; CaMos Research Group. Reply to: the association between cognitive decline and bone loss and fracture risk is not affected by medication with anticholinergic effect. J Bone Miner Res. May 2022;37(5):1075-1076. |
0 |
0 |
| 2022 |
Grace TM, O'Rourke D, Robertson T, Perilli E, Callary S, Taylor M, Atkins GJ, Solomon LB, Thewlis D. A semiautomated method to quantitatively assess osteolytic lesion volume and bone mineral density within acetabular regions of interest from CT. J Orthop Res. February 2022;40(2):396-408. |
0 |
0 |